U.S. Department of Justice

Showing 4896 articles
Business

Cinemark Stock: Undervalued Giant Poised for Rebound as Box Office Recovers

Despite lingering post-pandemic and industry headwinds, Cinemark Holdings (CNK) presents a compelling value case. With a dominant concession model, a massive loyalty program, and a slate of delayed blockbusters on the horizon, analysts see significant upside as the theater chain's financials stabilize and capital returns to shareholders begin.

Business

DaVita Navigates Headwinds as Integrated Kidney Care Turns Profitable Ahead of Schedule

DaVita Inc. reported Q4 2025 results in line with expectations, highlighting a milestone first profitable year for its Integrated Kidney Care unit. While revenue per treatment accelerated, the company continues to face pressure from elevated patient mortality and rising benefit costs. Executives provided 2026 guidance projecting mid-single-digit operating income growth and a sharp rise in EPS, buoyed by share buybacks and the stabilization of prior investment losses.